CellCarta is bringing structure to the complexity of spatial biology data with SPARTA. We know that more data is only more useful if you have the structures in place to extract the information you need. Learn more in our new blog post! 👉 https://t.co/oRToo8Aj6C

Did you miss our poster at AAPS 2025 Pharm Sci 360? Work from our proteomics team demonstrates how microsampling and mass spectrometry can be used for M-protein monitoring. 🔗 https://t.co/GH4qHc5yif Learn how we can support your patient monitoring: https://t.co/lQxcxxeH6w

Miss the validation report? See how we can simplify NSCLC biomarker detection. CellCarta has validated the Biofidelity Aspyre® assay to patient management standards, for use in tissue and blood samples. See the data for yourself in our full report 🔗 https://t.co/gYsFlg6IZn

Unlock deeper insights into gene expression and copy number variation with NanoString nCounter! 👉Analyze up to 800 genes in a single run 👉Rapid turnaround times 👉Sensitivity on par with RT-PCR Learn more about nCounter and contact our team today! 🔗 https://t.co/pDbmQ5z21w

Our team is all set up at #SITC2025! Make sure to stop by Booth 527 to talk all things biomarker strategy and logistics, and learn why we're the CRO partner of choice for your trials 🧬 🧪 🔬

We're looking forward to sharing some of our latest work at the upcoming Society for Immunotherapy of Cancer Annual Meeting. 📍Visit us at Booth 527 to talk to our experts, ask questions, and see how we can support your immunotherapy projects. 📅 https://t.co/IX7JVSBZ6Y

Don't miss our poster at AAPS 2025 PHarmSCi 360, presenting our latest work on M-protein monitoring in multiple myeloma. Reach out to learn more! https://t.co/m3oaPUIc4i 📅 November 9 - 12, 2025 📍San Antonio, TX 📢Poster Number: M1130-01-02

Today on International Pathology Day, we are proud to celebrate our dedicated pathologists at CellCarta. Thank you to our incredible pathology team for making a difference every day! #InternationalPathologyDay #TeamCellCarta

Our famous "falling blocks" game is on the road with us at #SITC2025 this year! Stop by Booth 527 to see if you can make it onto the leaderboard! James and our team are happy to share tips on strategy when it comes to both biomarkers and gaming 🎮 📅 https://t.co/IX7JVSBZ6Y

As we reach the end of #BreastCancerAwarenessMonth, we are so proud of our global CellCarta teams who participated in initiatives around the world to raise awareness and funds for breast cancer research. 💗Thank you to our amazing team for their passion and hard work. 💗

New Validation Report! If you work in the NSCLC space, this one is for you. CellCarta has validated the Biofidelity Aspyre® Lung assay to patient management standards, for use in tissue and blood samples. See the data for yourself in our full report 🔗 https://t.co/gYsFlg6IZn

👋We had such a great time at SITC last year, and the CellCarta team is thrilled to be heading to #SITC2025 - Will we see you there? 📍 Make sure to stop by Booth 527! 📅 November 5-9 Busy schedule? Book a meeting with our experts: https://t.co/IX7JVSBZ6Y

ADC programs underway? Understanding the regulatory approval process is key. Check out our newest blog post that breaks down the FDA guidance on ADCs! 🔗 https://t.co/bGUJWjhz8n #FDAguidance #ADCs #RegulatoryApprovals

🧬Did we miss you at #ESMO2025? Our poster shared validation data for the Biofidelity Aspyre assay, which we elevated to patient management standards for simplified mutational profiling in NSCLC. Get the full validation report here!👉 https://t.co/VXdcHKC6jg

The critical importance of regulatory T cells (Tregs) was recognized by the 2025 Nobel Prize in Physiology or Medicine. Learn more about the current focuses of Tregs in clinical work, and how to accurately assess Treg populations in our latest article! 🔗 https://t.co/9lGktUp6DP

Biomarkers and Precision Medicine US kicks off NEXT WEEK! 🌉 Jill Whitham and Neil O'Kane will be at booth #8, ready to discuss your wins and challenges in your biomarker strategy. Make sure to stop by! Busy schedule? Book a meeting with the team: https://t.co/TB05c9D3Ti

The @American College of Rheumatology meeting kicks off this week, and we are heading to Chicago! If you’re advancing your biomarker strategy or need support for your clinical projects, book a meeting or say hi to Simone on the conference floor! https://t.co/dinaAb9r6k #ACR25

🎯CellCarta is the first CRO to offer oncoReveal™ CDx pan-cancer solid tumor IVD for patient management. Learn how we can support your trial: https://t.co/yku8xnrUuX *Visit Pillar Biosciences website for details on regulatory approval: https://t.co/1XnavjpE6N

🤝Excited to connect at SITC 2025! We'll be at Booth #527. We are proud to partner with cancer immunotherapy innovators at every stage, from biomarker discovery to late-phase clinical trials. Visit us to learn how our expertise can support your program goals! #SITC2025

🗺️Don't let geography limit your PBMC sample plans! 📍Our global processing network includes labs around the world: US, Canada, Europe, Australia, and now with partners in Korea and Japan. Contact our logistics team to learn more 👉 https://t.co/ttLrXhwHbR